Poll: 33% of NFL fans 'purposely stopped watching' this season
A new poll suggests that 33% of NFL fans boycotted the league this season — but their motivations may surprise you.
Stocks surging because of fear of missing out: Investment…
Investors need to be careful as global stock markets continue to rally, Charles Newsome, divisional director at Investec Wealth and Investment, said.
Every bubble is created — and popped — by central banks: …
Ralph Jainz, fund manager at Centricus Asset Management, gives his thoughts on markets and central banks.
Two Major Shareholders Push Apple to Study Harmful Effects of Smartphone Addiction in Children
Two Major Shareholders Push Apple to Study Harmful Effects of Smartphone Addiction in Children
Celgene to buy Impact Biomedicines for up to $7 billion
U.S. biotech pharmaceutical firm Celgene Corp said on Sunday that it had agreed to acquire Impact Biomedicines for as much as $7 billion, subject to certain milestones associated with regulatory hurdles and sales performance. Celgene is interested in Impact Biomedicines' fedratinib, a kinase inhibitor that has shown promise as a potential treatment for a type of blood cancer called myelofibrosis, according to a statement put out jointly by both companies. "Myelofibrosis is a disease with high unmet medical need as the number of patients who are ineligible for or become resistant to existing therapy continues to increase," said Nadim Ahmed, Celgene's president of hematology and oncology.
NextBlock Global CEO Says Regulating Cryptocurrencies Will Be Tough
Jan.07 -- NextBlock Global Founder and CEO Alex Tapscott discusses cryptocurrency regulation with Bloomberg's Haslinda Amin on "Bloomberg Daybreak: Asia."
China's digital push in insurance is widening the playing…
Daniel Tu of Gen.Life says his firm is among newer players in the digital space in China's quickly changing insurance industry.